A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes
Clinical trial NCT07755150 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07755150
- Sponsor
- Chendu DIAO Pharmaceutical Group CO., LTD.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-30
- Primary completion
- 2027-10-20
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.